title: Surgery-associated acquired haemophilia and response to combined rituximab and cyclosporine treatment.
authors.forename: G
authors.initials: G
authors.lastname: Kam
authors.forename: Y S
authors.initials: YS
authors.lastname: Lee
authors.forename: T T
authors.initials: TT
authors.lastname: Tan
authors.forename: P
authors.initials: P
authors.lastname: Chow
authors.forename: H J
authors.initials: HJ
authors.lastname: Ng
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D015529:Choledochal Cyst / Q000601:surgery; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D011517:Prothrombin Time; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001779:Blood Coagulation Factors; D003524:Cyclosporins; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069283:Rituximab; C065655:anti-inhibitor coagulant complex